|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-3-5
|
|
pubmed:abstractText |
To evaluate single-dose and multiple-dose pharmacokinetics of cytotoxic T-lymphocyte-associated antigen 4 fusion protein (CTLA4Ig) in healthy volunteers and patients with rheumatoid arthritis (RA).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1745-7254
|
|
pubmed:author |
pubmed-author:BeiLinL,
pubmed-author:GuoYa-junYJ,
pubmed-author:HouShengS,
pubmed-author:LiBo-huaBH,
pubmed-author:LiJingJ,
pubmed-author:LinBi-rongBR,
pubmed-author:MaJianJ,
pubmed-author:MaYingY,
pubmed-author:QianWei-zhuWZ,
pubmed-author:SowO YOY,
pubmed-author:WangHaoH,
pubmed-author:WenAi-dongAD
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
364-71
|
|
pubmed:meshHeading |
pubmed-meshheading:19262560-Adult,
pubmed-meshheading:19262560-Aged,
pubmed-meshheading:19262560-Antirheumatic Agents,
pubmed-meshheading:19262560-Area Under Curve,
pubmed-meshheading:19262560-Arthritis, Rheumatoid,
pubmed-meshheading:19262560-Biological Markers,
pubmed-meshheading:19262560-Dose-Response Relationship, Drug,
pubmed-meshheading:19262560-Female,
pubmed-meshheading:19262560-Humans,
pubmed-meshheading:19262560-Immunoconjugates,
pubmed-meshheading:19262560-Male,
pubmed-meshheading:19262560-Middle Aged,
pubmed-meshheading:19262560-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Pharmacokinetics of CTLA4Ig fusion protein in healthy volunteers and patients with rheumatoid arthritis.
|
|
pubmed:affiliation |
Shanghai Key Laboratory of Cell Engineering and Shanghai National Engineering Research Center for Antibody Medicine, Shanghai, China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|
